| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Seres Therapeutics, Inc. | Executive Vice President and Chief Technology Officer | Common Stock | 75.7K | $71.2K | $0.94 | May 15, 2024 | Direct |
| Seres Therapeutics, Inc. | Executive Vice President and Chief Technology Officer | Restricted Stock Units | 32.7K | $30.7K | $0.94 | May 15, 2024 | Direct |
| Seres Therapeutics, Inc. | Executive Vice President and Chief Technology Officer | Stock Option (Right to Buy) | 288K | Feb 14, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| MCRB | Seres Therapeutics, Inc. | May 15, 2024 | 3 | -$1.02K | 4 | May 17, 2024 | Executive Vice President and Chief Technology Officer |
| MCRB | Seres Therapeutics, Inc. | Feb 14, 2024 | 6 | -$5.41K | 4 | Feb 16, 2024 | Executive Vice President and Chief Technology Officer |
| MCRB | Seres Therapeutics, Inc. | Oct 27, 2023 | 4 | -$5.49K | 4 | Oct 31, 2023 | Executive Vice President and Chief Technology Officer |
| MCRB | Seres Therapeutics, Inc. | Apr 27, 2023 | 2 | -$36.5K | 4 | May 1, 2023 | Executive Vice President and Chief Technology Officer |
| MCRB | Seres Therapeutics, Inc. | Feb 3, 2023 | 2 | $0 | 4 | Feb 7, 2023 | Executive Vice President and Chief Technology Officer |
| MCRB | Seres Therapeutics, Inc. | Oct 27, 2022 | 2 | -$39.7K | 4 | Oct 31, 2022 | Executive Vice President and Chief Technology Officer |
| MCRB | Seres Therapeutics, Inc. | Jul 5, 2022 | 1 | $100K | 4 | Jul 6, 2022 | Executive Vice President and Chief Technology Officer |
| MCRB | Seres Therapeutics, Inc. | Feb 4, 2022 | 1 | $0 | 4 | Feb 8, 2022 | Executive Vice President and Chief Technology Officer |